Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: Prevalence, risk factors, and association with low birth weight

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 3, 1999, Pages 656-662

  Sutton, Madeline Y ^a,d   Sternberg, Maya ^a   Nsuami, Malanda ^b   Behets, Frieda ^b   Nelson, Ann Marie ^b,c   St Louis, Michael E ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Projet SIDA (Project AIDS)   (United States)

^c Armed Forces Institute of Pathology   (Congo)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Human immunodeficiency virus; Low birth weight; Trichomoniasis

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONGO; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TRICHOMONIASIS;

EID: 0032825198     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70509-0     Document Type: Article

References (26)

1. 1. Hammill HA. Trichomonas vaginalis. Obstet Gynecol Clin North Am 1989;16:531-40.
2. 2. Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997;24:353-60.
3. 3. Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72.
4. 4. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995;173:1231-5.
5. 5. Pastorek JG, Cotch MF, Martin DH, Eschenbach DA. Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. Clin Infect Dis 1996;23:1075-80.
6. 6. Hardy PH, Hardy JB, Nell EE, Graham DA, Spence MR, Rosenbaum RC. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 1984;2:333-7.
7. 7. Wolner-Hanssen P, Krieger JN, Stevens CE, Kiviat NB, Koutsky L, Critchlow C, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989;261:571-6.
8. 8. Draper D, Parker R, Patterson E, Jones W, Beutz M, French J, et al. Detection of Trichomonas vaginalis in pregnant women with the inpouch TV culture system. J Clin Microbiol 1993;31:1016-8.
9. 9. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
10. 10. Ecker JL. The cost-effectiveness of human immunodeficiency virus screening in pregnancy. Am J Obstet Gynecol 1996;174:716-21.
11. 11. Braddick MR, Kreiss JK, Embree JB, Datta P, Ndinya-Achola JO, Pamba H, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS 1990;4:1001-5.
12. 12. Temmerman M, Chomba EN, Ndinya-Achola J, Plummer FA, Coppeus M, Piot P. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994;83:495-501.
13. 13. St. Louis ME, Kamenga M, Brown C, Nelson AM, Manzila T, Batter V. Risk for HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993; 269:2853-9.
14. 14 Van Dyck E, Piot P, Meheus A. Bench-level manual for sexually transmitted diseases. Geneva (Switzerland): World Health Organization; 1989. WHO/VDT/89.443:55-6.
15. 15. Ballard JL, Novak KK, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979;95:769-74.
16. 16. Ghys PD, Diallo MO, Ettiegne-Traore V, Yebone KM, Gnaore E, Lorougnon F, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995;172:1371-4.
17. 17. Sorvillo FJ, Kovacs A, Kerndt P, Stek A, Muderspach L, Sanchez-Keeland L. Risk factors for trichomoniasis among women with HIV infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg 1998;58:495-500.
18. 18. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs, RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth weight infant. N Engl J Med 1995;333:1737-42.
19. 19. Govender L, Hoosen AA, Moodley J, Sturm AW. Bacterial vaginosis and associated infections in pregnancy. Int J Gynaecol Obstet 1996;55:23-8.
20. 20. Fouts A, Kraus SJ. Trichomonas vaginalis, reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980;141:137-43.
21. 21. Chaisilwattana P, Chuachoowong R, Siriwasin W, Bhadrakom C, Mangclaviraj Y, Young N. et al. Chlamydial and gonococcal cervicitis in HIV-seropositive and HIV-seronegative pregnant women in Bangkok: prevalence, risk factors, and relation to perinatal HIV transmission. Sex Transm Dis 1997;24:495-502.
22. 22. McGregor JA, French JI, Parker R, Draper D, Patterson E. Jones W, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
23. 23. Alderete JF, Provenzano D. The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases. Sex Transm Infect 1997;73:291-6.
24. 24. Mirhaghani A, Warton A. An electron microscopy study of the interaction between Trichomonas vaginalis and epithelial cells of the human amnion membrane. Parasitol Res 1996;82:43-7.
25. 25. Schwebke JR, Morgan SC, Pinson GB. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol 1997;35:1618-9.
26. 26. Wawer MJ, McNairn D, Wabwire-Mangen F, Paxton L, Gray RH, Kiwanuka N. Self-administered vaginal swabs for population-based assessment of Trichomonas vaginalis prevalence. Lancet 1995;345:131-2.